On September 14, 2020 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, reported that John Melo, President and Chief Executive Officer, will provide a business overview and update on current affairs during the H.C. Wainwright 22nd Annual Global Investment Virtual Conference today (Press release, Amyris Biotechnologies, SEP 14, 2020, https://www.prnewswire.com/news-releases/amyris-to-provide-business-overview-and-update-on-current-affairs-at-hc-wainwright-22nd-annual-global-investment-conference-today-301129839.html [SID1234565126]). The company will also be participating in virtual one-on-one meetings during the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company’s presentation is at 10:00 a.m. ET today. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company’s website at View Source Due to the format of the virtual conference, no audience question and answer session will be available.